Angelman syndrome

The companies will work together to identify novel biomarkers of the rare genetic disorder Angelman syndrome.

BioArray Briefs

Premium

Baylor College of Medicine, Illumina, Aushon Biosystems, SciGene, Invitrogen

Baylor will use the arrays for studying genomic imprinting and its role in developmental diseases.

Quest plans to develop and sell a diagnostic for prostate cancer based on the biomarker.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.